FIDSON Stock Overview
Manufactures and distributes pharmaceutical products in Nigeria.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Fidson Healthcare Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₦14.75 |
| 52 Week High | ₦19.20 |
| 52 Week Low | ₦13.14 |
| Beta | 0.089 |
| 11 Month Change | -1.34% |
| 3 Month Change | 2.79% |
| 1 Year Change | -1.21% |
| 33 Year Change | 149.62% |
| 5 Year Change | 260.56% |
| Change since IPO | 415.08% |
Recent News & Updates
Recent updates
Shareholder Returns
| FIDSON | NG Pharmaceuticals | NG Market | |
|---|---|---|---|
| 7D | 0% | 3.5% | -0.6% |
| 1Y | -1.2% | 17.0% | 70.7% |
Return vs Industry: FIDSON underperformed the NG Pharmaceuticals industry which returned 17% over the past year.
Return vs Market: FIDSON underperformed the NG Market which returned 70.7% over the past year.
Price Volatility
| FIDSON volatility | |
|---|---|
| FIDSON Average Weekly Movement | 5.4% |
| Pharmaceuticals Industry Average Movement | 4.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in NG Market | 9.7% |
| 10% least volatile stocks in NG Market | 2.8% |
Stable Share Price: FIDSON has not had significant price volatility in the past 3 months.
Volatility Over Time: FIDSON's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 650 | Fidelis Ayebae | fidson.com |
Fidson Healthcare Plc manufactures and distributes pharmaceutical products in Nigeria. The company operates in three segments: Over-the-Counter, Ethical Products, and Consumer Healthcare Product. It offers drugs, infusions, and injectables.
Fidson Healthcare Plc Fundamentals Summary
| FIDSON fundamental statistics | |
|---|---|
| Market cap | ₦33.85b |
| Earnings (TTM) | ₦3.28b |
| Revenue (TTM) | ₦60.53b |
10.3x
P/E Ratio0.6x
P/S RatioIs FIDSON overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FIDSON income statement (TTM) | |
|---|---|
| Revenue | ₦60.53b |
| Cost of Revenue | ₦36.97b |
| Gross Profit | ₦23.56b |
| Other Expenses | ₦20.28b |
| Earnings | ₦3.28b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.43 |
| Gross Margin | 38.92% |
| Net Profit Margin | 5.42% |
| Debt/Equity Ratio | 144.4% |
How did FIDSON perform over the long term?
See historical performance and comparison